GSK plc (GLAXF)
USD 16.84
(0.0%)
USD 16.84
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.74 Billion GBP | 8.71% |
| 2022 | 6.43 Billion GBP | 3.74% |
| 2021 | 6.2 Billion GBP | -20.33% |
| 2020 | 7.78 Billion GBP | 11.81% |
| 2019 | 6.96 Billion GBP | 26.96% |
| 2018 | 5.48 Billion GBP | 34.16% |
| 2017 | 4.08 Billion GBP | 57.31% |
| 2016 | 2.59 Billion GBP | -74.83% |
| 2015 | 10.32 Billion GBP | 186.96% |
| 2014 | 3.59 Billion GBP | -48.82% |
| 2013 | 7.02 Billion GBP | -4.92% |
| 2012 | 7.39 Billion GBP | -5.32% |
| 2011 | 7.8 Billion GBP | 106.37% |
| 2010 | 3.78 Billion GBP | -55.1% |
| 2009 | 8.42 Billion GBP | 17.98% |
| 2008 | 7.14 Billion GBP | -5.95% |
| 2007 | 7.59 Billion GBP | -2.75% |
| 2006 | 7.8 Billion GBP | 13.59% |
| 2005 | 6.87 Billion GBP | 19.42% |
| 2004 | 5.75 Billion GBP | -9.72% |
| 2003 | 6.37 Billion GBP | 14.86% |
| 2002 | 5.55 Billion GBP | -9.05% |
| 2001 | 6.1 Billion GBP | 29.06% |
| 2000 | 4.72 Billion GBP | 80.15% |
| 1999 | 2.62 Billion GBP | -2.16% |
| 1998 | 2.68 Billion GBP | -4.93% |
| 1997 | 2.82 Billion GBP | -9.9% |
| 1996 | 3.13 Billion GBP | 31.49% |
| 1995 | 2.38 Billion GBP | 31.1% |
| 1994 | 1.81 Billion GBP | 19.15% |
| 1993 | 1.52 Billion GBP | 18.49% |
| 1992 | 1.28 Billion GBP | -5.23% |
| 1991 | 1.35 Billion GBP | 10.77% |
| 1990 | 1.22 Billion GBP | 18.8% |
| 1989 | 1.03 Billion GBP | 20.98% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.98 Billion GBP | 0.1% |
| 2024 Q1 | 1.98 Billion GBP | 88.5% |
| 2024 Q3 | 189 Million GBP | -90.48% |
| 2023 FY | 6.99 Billion GBP | 8.71% |
| 2023 Q4 | 1.05 Billion GBP | -46.02% |
| 2023 Q1 | 2.08 Billion GBP | 11.46% |
| 2023 Q2 | 2.14 Billion GBP | 2.83% |
| 2023 Q3 | 1.94 Billion GBP | -8.97% |
| 2022 Q3 | 1.19 Billion GBP | 10.18% |
| 2022 Q1 | 2.8 Billion GBP | 212.96% |
| 2022 Q2 | 1.08 Billion GBP | -61.41% |
| 2022 FY | 6.43 Billion GBP | 3.74% |
| 2022 Q4 | 1.86 Billion GBP | 56.84% |
| 2021 Q1 | 1.69 Billion GBP | 59.57% |
| 2021 Q4 | 895 Million GBP | -53.82% |
| 2021 Q3 | 1.93 Billion GBP | 15.7% |
| 2021 Q2 | 1.67 Billion GBP | -1.06% |
| 2021 FY | 6.2 Billion GBP | -20.33% |
| 2020 FY | 7.78 Billion GBP | 11.81% |
| 2020 Q4 | 1.06 Billion GBP | -42.9% |
| 2020 Q1 | 2.01 Billion GBP | 5.89% |
| 2020 Q3 | 1.85 Billion GBP | -34.81% |
| 2020 Q2 | 2.85 Billion GBP | 41.51% |
| 2019 Q3 | 2.14 Billion GBP | 44.68% |
| 2019 Q1 | 1.42 Billion GBP | -8.11% |
| 2019 Q4 | 1.9 Billion GBP | -11.41% |
| 2019 Q2 | 1.48 Billion GBP | 3.92% |
| 2019 FY | 6.96 Billion GBP | 26.96% |
| 2018 Q4 | 1.55 Billion GBP | -18.64% |
| 2018 Q2 | 779 Million GBP | -37.18% |
| 2018 Q1 | 1.24 Billion GBP | 142.19% |
| 2018 FY | 5.48 Billion GBP | 34.16% |
| 2018 Q3 | 1.91 Billion GBP | 145.19% |
| 2017 Q1 | 1.71 Billion GBP | 188.74% |
| 2017 Q3 | 1.87 Billion GBP | 9485.0% |
| 2017 Q2 | -20 Million GBP | -101.16% |
| 2017 FY | 4.08 Billion GBP | 57.31% |
| 2017 Q4 | 512 Million GBP | -72.72% |
| 2016 Q1 | 723 Million GBP | 384.65% |
| 2016 Q2 | -151 Million GBP | -120.89% |
| 2016 FY | 2.59 Billion GBP | -74.83% |
| 2016 Q3 | 1.43 Billion GBP | 1047.68% |
| 2016 Q4 | 595 Million GBP | -58.42% |
| 2015 Q3 | 1.02 Billion GBP | 205.97% |
| 2015 Q2 | 335 Million GBP | -96.37% |
| 2015 Q1 | 9.21 Billion GBP | 1233.72% |
| 2015 Q4 | -254 Million GBP | -124.78% |
| 2015 FY | 10.32 Billion GBP | 186.96% |
| 2014 Q3 | 703 Million GBP | -38.17% |
| 2014 Q4 | 691 Million GBP | -1.71% |
| 2014 Q2 | 1.13 Billion GBP | 6.66% |
| 2014 Q1 | 1.06 Billion GBP | -56.33% |
| 2014 FY | 3.59 Billion GBP | -48.82% |
| 2013 Q4 | 2.44 Billion GBP | 55.58% |
| 2013 Q3 | 1.56 Billion GBP | 9.11% |
| 2013 Q2 | 1.43 Billion GBP | -8.99% |
| 2013 Q1 | 1.58 Billion GBP | -18.56% |
| 2013 FY | 7.02 Billion GBP | -4.92% |
| 2012 FY | 7.39 Billion GBP | -5.32% |
| 2012 Q4 | 1.94 Billion GBP | 15.54% |
| 2012 Q3 | 1.67 Billion GBP | -3.28% |
| 2012 Q2 | 1.73 Billion GBP | -14.78% |
| 2012 Q1 | 2.03 Billion GBP | 8.41% |
| 2011 FY | 7.8 Billion GBP | 106.37% |
| 2011 Q2 | 1.77 Billion GBP | -12.63% |
| 2011 Q3 | 2.11 Billion GBP | 18.95% |
| 2011 Q1 | 2.03 Billion GBP | 735.94% |
| 2011 Q4 | 1.87 Billion GBP | -11.16% |
| 2010 FY | 3.78 Billion GBP | -55.1% |
| 2010 Q3 | 1.95 Billion GBP | 3739.22% |
| 2010 Q4 | -320 Million GBP | -116.34% |
| 2010 Q1 | 2.09 Billion GBP | -14.43% |
| 2010 Q2 | 51 Million GBP | -97.56% |
| 2009 Q3 | 2.07 Billion GBP | -5.65% |
| 2009 FY | 8.42 Billion GBP | 17.98% |
| 2009 Q4 | 2.44 Billion GBP | 18.16% |
| 2009 Q1 | 1.71 Billion GBP | 8.22% |
| 2009 Q2 | 2.19 Billion GBP | 28.21% |
| 2008 FY | 7.14 Billion GBP | -5.95% |
| 2008 Q1 | 1.96 Billion GBP | 1.5% |
| 2008 Q4 | 1.58 Billion GBP | -4.53% |
| 2008 Q3 | 1.65 Billion GBP | -14.54% |
| 2008 Q2 | 1.93 Billion GBP | -1.22% |
| 2007 Q2 | 1.92 Billion GBP | -10.94% |
| 2007 Q1 | 2.16 Billion GBP | 27.58% |
| 2007 Q3 | 51.81 Million GBP | -97.31% |
| 2007 FY | 7.59 Billion GBP | -2.75% |
| 2007 Q4 | 1.93 Billion GBP | 3632.42% |
| 2006 Q2 | 1.91 Billion GBP | -12.08% |
| 2006 Q4 | 1.69 Billion GBP | -16.08% |
| 2006 Q1 | 2.17 Billion GBP | 144.57% |
| 2006 Q3 | 2.02 Billion GBP | 5.84% |
| 2006 FY | 7.8 Billion GBP | 13.59% |
| 2005 Q2 | 1.7 Billion GBP | -2.22% |
| 2005 Q3 | 1.78 Billion GBP | 4.38% |
| 2005 Q4 | -4.87 Billion GBP | -373.54% |
| 2005 FY | 6.87 Billion GBP | 19.42% |
| 2005 Q1 | 1.74 Billion GBP | 7.02% |
| 2004 FY | 5.75 Billion GBP | -9.72% |
| 2004 Q4 | 1.63 Billion GBP | 9.01% |
| 2004 Q2 | 1.52 Billion GBP | 2.14% |
| 2004 Q3 | 1.49 Billion GBP | -1.81% |
| 2004 Q1 | 1.49 Billion GBP | 30.57% |
| 2003 Q1 | 1.69 Billion GBP | 25.99% |
| 2003 FY | 6.37 Billion GBP | 14.86% |
| 2003 Q4 | 1.14 Billion GBP | -31.53% |
| 2003 Q3 | 1.67 Billion GBP | -10.71% |
| 2003 Q2 | 1.87 Billion GBP | 10.05% |
| 2002 Q4 | 1.34 Billion GBP | 19.8% |
| 2002 Q1 | 1.43 Billion GBP | -46.86% |
| 2002 FY | 5.55 Billion GBP | -9.05% |
| 2002 Q2 | 1.64 Billion GBP | 14.36% |
| 2002 Q3 | 1.12 Billion GBP | -31.38% |
| 2001 Q4 | 2.7 Billion GBP | 170.29% |
| 2001 FY | 6.1 Billion GBP | 29.06% |
| 2001 Q1 | 1.04 Billion GBP | -17.61% |
| 2001 Q2 | 1.35 Billion GBP | 29.39% |
| 2001 Q3 | 999 Million GBP | -26.33% |
| 2000 FY | 4.72 Billion GBP | 80.15% |
| 2000 Q1 | 1.16 Billion GBP | 134.08% |
| 2000 Q2 | 1.16 Billion GBP | -0.43% |
| 2000 Q3 | 1.12 Billion GBP | -3.44% |
| 2000 Q4 | 1.27 Billion GBP | 13.17% |
| 1999 Q3 | 2.27 Billion GBP | 243.54% |
| 1999 Q2 | 662.46 Million GBP | -67.07% |
| 1999 FY | 2.62 Billion GBP | -2.16% |
| 1999 Q1 | 2.01 Billion GBP | 166.05% |
| 1999 Q4 | -3.43 Billion GBP | -250.72% |
| 1998 Q2 | 611.25 Million GBP | -68.36% |
| 1998 Q1 | 1.93 Billion GBP | 159.85% |
| 1998 Q4 | -3.04 Billion GBP | -248.07% |
| 1998 FY | 2.68 Billion GBP | -4.93% |
| 1998 Q3 | 2.05 Billion GBP | 236.57% |
| 1997 Q4 | -3.22 Billion GBP | -261.17% |
| 1997 Q3 | 2 Billion GBP | -0.5% |
| 1997 Q2 | 2.01 Billion GBP | -1.58% |
| 1997 Q1 | 2.04 Billion GBP | 217.68% |
| 1997 FY | 2.82 Billion GBP | -9.9% |
| 1996 Q4 | -1.73 Billion GBP | -169.82% |
| 1996 Q3 | 2.48 Billion GBP | 19.0% |
| 1996 Q1 | 2.12 Billion GBP | 0.0% |
| 1996 FY | 3.13 Billion GBP | 31.49% |
| 1996 Q2 | 2.09 Billion GBP | -1.69% |
| 1995 FY | 2.38 Billion GBP | 31.1% |
| 1995 Q3 | 1.62 Billion GBP | 148.79% |
| 1995 Q2 | -3.34 Billion GBP | -309.02% |
| 1995 Q1 | 1.59 Billion GBP | -3.17% |
| 1994 FY | 1.81 Billion GBP | 19.15% |
| 1994 Q1 | 1.51 Billion GBP | 6.89% |
| 1994 Q2 | -2.46 Billion GBP | -262.18% |
| 1994 Q3 | 1.63 Billion GBP | 166.29% |
| 1994 Q4 | 1.65 Billion GBP | 1.03% |
| 1993 Q3 | 1.39 Billion GBP | 166.17% |
| 1993 Q2 | -2.1 Billion GBP | -239.49% |
| 1993 Q1 | 1.5 Billion GBP | 31.64% |
| 1993 FY | 1.52 Billion GBP | 18.49% |
| 1993 Q4 | 1.42 Billion GBP | 2.05% |
| 1992 Q3 | 977.28 Million GBP | 152.27% |
| 1992 Q4 | 1.14 Billion GBP | 17.3% |
| 1992 FY | 1.28 Billion GBP | -5.23% |
| 1992 Q1 | 1.11 Billion GBP | 7.51% |
| 1992 Q2 | -1.86 Billion GBP | -266.95% |
| 1991 FY | 1.35 Billion GBP | 10.77% |
| 1991 Q1 | 793.32 Million GBP | 10.95% |
| 1991 Q4 | 1.04 Billion GBP | -6.3% |
| 1991 Q3 | 1.11 Billion GBP | 208.78% |
| 1991 Q2 | -1.02 Billion GBP | -228.82% |
| 1990 Q4 | 715 Million GBP | -2.76% |
| 1990 Q1 | 784.13 Million GBP | 4.18% |
| 1990 FY | 1.22 Billion GBP | 18.8% |
| 1990 Q2 | -1.02 Billion GBP | -231.2% |
| 1990 Q3 | 735.3 Million GBP | 171.48% |
| 1989 Q3 | 743.77 Million GBP | 199.32% |
| 1989 Q2 | -748.88 Million GBP | -228.72% |
| 1989 Q1 | 581.8 Million GBP | 3.51% |
| 1989 FY | 1.03 Billion GBP | 20.98% |
| 1989 Q4 | 752.7 Million GBP | 1.2% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AstraZeneca PLC | 8.19 Billion USD | 17.674% |
| Bristol-Myers Squibb Company PFD CONV 2 | 17.24 Billion USD | 60.88% |
| CSPC Pharmaceutical Group Limited | 7.01 Billion USD | 3.863% |
| Clarus Therapeutics Holdings, Inc. | -39.73 Million USD | 17076.241% |
| Novartis AG | 9.76 Billion USD | 30.955% |
| PT Kalbe Farma Tbk. | 3625.13 Billion USD | 99.814% |